Moderna (MRNA) surged about 177% after it and Merck (MRK) reported the first positive Phase 3 result for an mRNA cancer ...

Moderna just transformed from a cash-burning vaccine maker into a serious acquirer, and four biotech targets are already ...

Read Moderna Vaccine latest news on The Economic Times. Moderna Vaccine updates, Moderna Vaccine videos & more.

Moderna and Merck scored a big win for their cancer vaccine on Wednesday. But analysts say it's too early to call it a home ...

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

Merck and Moderna's personalised cancer vaccine shows promise against melanoma, reducing recurrence risk. This mRNA-based ...

Operator: Good day, and thank you for standing by. Valneva presents its half year 2026 financial results. [Operator ...

Get step-by-step guidance on investing in Johnson & Johnson stock and learn the ins and outs of this healthcare company. The medical device market is expected to grow to almost $800 billion by 2030.

Pumitamig plus B7H3-targeting elfetabart drozuntecan delivers the first data in lung cancer for any PD-(L)1xVEGF bispecific immunomodulator combined with an antibody-drug conjugate, underscoring BioNT ...

City officials announced late Tuesday that the frozen zone around the unstable Manhattan building has been reduced, allowing some pedestrians and traffic back into the area. Ahmed Tigani, commissioner ...

Spread the loveImagine a future where your cancer treatment isn’t a blunt instrument, but a precision-guided missile, ...